Showing posts with label PTSD. Show all posts
Showing posts with label PTSD. Show all posts

Sunday, May 1, 2011

More Toxins More Problems: Cancer Treatment

Years ago I learned that the impact of chemo and radiation created a very toxic state in the body, often an unspoken cause of death from cancer therapy in western medicine.  Detoxification and timing of treatment can go a very long way in improving outcomes.  SSRIs are not included.

from the UK - Daily Telegraph

"BREAST CANCER PATIENTS SUFFER FROM SOLDIERS' STRESS DISORDER"

45% of breast cancer patients suffer Post Traumatic Stress Disorder, even years after diagnosis, a study has found. They suffer anxiety, depression, nightmares & mood swings etc. This can be caused by the frightening diagnosis of breast cancer, the stress of surgery or chemotherapy.

Research at Panteion University, Athens. who say that doctors need a plan to assist cancer patients with this aspect of their experience.

Half of breast cancer patients 'suffer symptoms of post-traumatic stress disorder'

Almost half of breast cancer patients suffer symptoms of post-traumatic stress disorder even years after diagnosis, according to a new study.

The debilitating disorder is often characterised by agitation, anxiety, depression, nightmares, flashbacks, and mood swings.
It is more often associated with soldiers returning from battlefields who have been shell-shocked by their experiences.
But now doctors have found that a similar effect can be found in women told that they have breast cancer.
The researchers behind the study believe that a combination of factors could trigger the condition.
These include the effects of a frightening diagnosis like breast cancer combined with the stress of treatment, such as surgery or chemotherapy, as well as other unexpected consequences, such as patients having to give up work.
Revealingly, the doctors found that even those women whose therapy has been successful and whose cancer has gone into remission can exhibit symptoms of the disorder.
Their study looked at the effects of the disease on 331 women treated in a Greek hospital.
They found that, overall, 45 per cent of the patients showed symptoms of post-traumatic stress disorder (PTSD).
What is more the women reported that they were suffering from the symptoms, and also had a poorer quality of life, three years after their diagnosis and treatment.
The researchers, from the Panteion University of Athens, warn that doctors should watch out for the signs of the condition when they are treating patients with breast cancer.
They warn: “Knowing that breast cancer patients are susceptible to PTSD, it might be necessary for the field of medicine to create a plan in assisting cancer patients that takes into account the entire spectrum of a patient’s experience with the illness.”
More than 45,000 women in Britain develop breast cancer every year, and one in three of them will go on to die from the disease.
Overall, experts estimate that a woman has a one in nine chance of developing breast cancer over the course of her lifetime.
The findings were presented at the Impakt Breast Cancer Conference in Brussels.
Emma Pennery, from the charity Breast Cancer Care, said: “The principle that women, and men, will have an ongoing risk of anxiety and depression following a diagnosis of breast cancer is well known, and there is a range of national guidance in the UK which covers the role of health care professionals in providing ongoing emotional support to patients. “
Last year doctors reported that having a heart attack could also trigger symptoms of PTSD.
Almost one in six patients, 16 per cent, met the criteria for the condition, while another 18 per cent suffered some symptoms of the disorder.

Thursday, October 28, 2010

14 Percent May Have PTSD: WAR REPORT

For related information please see Veteran's Resources
SILVER SPRING, Md., June 9 (UPI) -- Between 8.5 percent and 14 percent of U.S. soldiers returning from Iraq report either post-traumatic stress disorder or depression, researchers found.

Jeffrey L. Thomas of the Walter Reed Army Institute of Research in Silver Spring, Md., and colleagues analyzed anonymous mental health surveys of 18,305 U.S. Army soldiers -- reserve and non-reserve -- three to 12 months after deployment.

The soldiers were screened for PTSD, depression, alcohol misuse and aggressive behaviors.
"Using the least stringent definition, we observed PTSD rates across Active Component and National Guard study groups, study time points ranging from 20.7 percent to 30.5 percent, and depression rates ranging from 11.5 percent to 16 percent," the study authors said in a statement. "Using the strictest definitions with high symptom rates and serious functional impairment, PTSD prevalence ranged from 5.6 percent to 11.3 percent and depression prevalence from 5 percent to 8.5 percent."

The study, published in the Archives of General Psychiatry, shows that at 12 months after combat, mental health problems among veterans do not abate, and in many cases, increase, Thomas said.

"If soldiers who are struggling with serious functional impairment as the result of a previous deployment are deployed again, there is potential that this could impair their performance in combat," the study said. "This has implications for the safety of unit members and mission success."

Thursday, September 2, 2010

Veterans, Psych Drugs, and Deaths

Recently reported in Marine Corps Times and other media venues including Preventive Psychiatry E-Newsletter, it has been noted that psychotropic drug-induced sudden deaths are increasing in Iraq War Veterans.

Most of the newer psych drugs are fluoride based and are known to have cardiac effects among the many problems they cause.

Other over looked problems may be from depleted uranium exposure.

If you suppress respiratory function enough you will impact heart function because of low oxygen levels. Old studies showed that low O2 levels in the blood caused more deaths at 4 AM and that often there was evidence of cardiac arrythmia.

Read complete article
Interactions: Combined Seroquel, Klonopin, Paxil
clonazepam ↔ paroxetine
Applies to: Klonopin (clonazepam), Paxil (paroxetine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

clonazepam ↔ quetiapine
Applies to: Klonopin (clonazepam), Seroquel (quetiapine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

paroxetine ↔ quetiapine
Applies to: Paxil (paroxetine), Seroquel (quetiapine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

MANAGEMENT: During concomitant use of these three drugs, patients should be monitored for potentially excessive or prolonged CNS and respiratory depression . Ambulatory patients should be counseled to avoid hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.